References
- ChungWHChangWCLeeYSGenetic variants associated with phenytoin-related severe cutaneous adverse reactionsJAMA2014312552553425096692
- TangamornsuksanWChaiyakunaprukNSomkruaRLohitnavyMTassaneeyakulWRelationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysisJAMA Dermatol201314991025103223884208
- ManuyakornWSiripoolKKamchaisatianWPhenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai childrenPediatr Allergy Immunol201324329930323551241
- Exome Aggregation Consortium (ExAC) Available from: http://exac.broadinstitute.org/variant/10-96541616-G-AAccessed June 13, 2016
- NCBI dbSNP Short Genetic Variations Available from: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4244285Accessed June 13, 2016
- WeinshilboumRInheritance and drug responseN Engl J Med2003348652953712571261
- DalyAKKingBPPharmacogenetics of oral anticoagulantsPharmacogenetics200313524725212724615
- ScottSASangkuhlKGardnerEEClinical pharmacogenetics implementation consortium guidelines for cytochrome P450–2C19 (CYP2C19) genotype and clopidogrel therapyClin Pharmacol Ther201190232833221716271